相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Doxorubicin-induced senescence through NF-κB affected by the age of mouse mesenchymal stem cells
Ali Bashiri Dezfouli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Integrative discovery of treatments for high-risk neuroblastoma
Elin Almstedt et al.
NATURE COMMUNICATIONS (2020)
Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
Jing Zhao et al.
CHINESE MEDICAL JOURNAL (2020)
State of the art in immunotherapy of neuroblastoma
Parnian Jabbari et al.
IMMUNOTHERAPY (2019)
Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
Shen-Jun Yuan et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
Robin Parihar et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Cellular components in tumor microenvironment of neuroblastoma and the prognostic value
Xiaodan Zhong et al.
PEERJ (2019)
Reduction of myeloid-derived suppressor cells reinforces the anti-solid tumor effect of recipient leukocyte infusion in murine neuroblastoma-bearing allogeneic bone marrow chimeras
Isabelle Dierckx de Casterle et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children
Qian Zhao et al.
CHINESE MEDICAL JOURNAL (2018)
Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
Thitinee Vanichapol et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
Irina V. Kholodenko et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Advances in the Surgical Treatment of Neuroblastoma
Yan-Bing Luo et al.
CHINESE MEDICAL JOURNAL (2018)
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2018)
Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
Fabio Morandi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Microenvironment-Driven Shift of Cohesion/Detachment Balance within Tumors Induces a Switch toward Metastasis in Neuroblastoma
Celine Delloye-Bourgeois et al.
CANCER CELL (2017)
Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy
Damiana Antonia Fae et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh et al.
CANCER RESEARCH (2014)
分享论文
